Since the catabolism and growth impairment are well-known complications of IBD, Eivindson et al. [76] found a correlation between IGF-2 and IL-6 in IBD patients, suggesting an association between inflammation and the IGF system with involvement in muscle and bone catabolism in IBD pathogenesis. Here, IL6 is linked to inflammatory bowel disease.